Pantherx Specialty, LLC
Pittsburgh, PA Doing business as Pantherx Specialty Pharmacy
- UEI
- EG8MVF1BJ9H6
- CAGE
- 82BT8
- Primary NAICS
- 456110 Pharmacies and Drug Retailers
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 121 Bayer Rd Bldg 5, Pittsburgh, PA 15205, USA
- Website
- pantherxrare.com
- Founded
- 2011
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health & Wellness
- SIC code
- 59 Miscellaneous Retail
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $107,424 |
| FY2026 | $604,023 |
| FY2025 | $231,613 |
| FY2024 | $0 |
| FY2023 | $97,383 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Justice | $577,736 | |
| 2 | Department of Veterans Affairs | $133,711 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Mckesson Plasma And Biologics LLC | Shepherdsville, KY | 325412 Pharmaceutical Preparation Manufacturing |
| CVS Health Corporation | Woonsocket, RI | 456110 Pharmacies and Drug Retailers |
| Procare Pharmacy Direct, L.L.C. | Monroeville, PA | 456110 Pharmacies and Drug Retailers |
| Eversana Life Science Services LLC | Milwaukee, WI | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Chartwell RX LLC | Congers, NY | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Pantherx Specialty, LLC, doing business as Pantherx Specialty Pharmacy, supplies rare disease and specialty medications to the Department of Veterans Affairs and the Department of Justice Bureau of Prisons as a prime contractor on firm fixed-price purchase orders, with no set-aside designations. A for-profit limited liability company and subsidiary of Centene Corporation headquartered in Pittsburgh, Pennsylvania, Pantherx Specialty operates exclusively in full-and-open federal procurement and competes without SBA set-aside protections.
The vendor's federal footprint centers on emergency and routine pharmaceutical supply to two customer clusters: the VA's Veterans Integrated Service Networks and the Bureau of Prisons' medical centers. Combined potential value across 53 recent prime awards stands at $1.6 million, with $1.5 million obligated (94% execution rate), reflecting the transactional nature of small-dollar, rapid-cycle pharmaceutical purchase orders. Activity accelerated sharply in 2025, rising from 1 award in 2024 to 28 in 2025, and has continued at elevated volume through October 2026 with 16 awards year-to-date. The vendor serves five distinct customer agencies, all within the healthcare-delivery arms of VA and DOJ.
Customer concentration by dollar value diverges from award count. The Bureau of Prisons Federal Medical Center Rochester leads by combined potential value at $659 thousand across 14 awards, but the VA Veterans Integrated Service Network 2 places the most orders (28 awards) at $297 thousand combined potential value. Veterans Integrated Service Network 16 ranks second by dollars at $443 thousand across 5 awards. This pattern reflects Pantherx Specialty's role as a high-velocity, low-dollar-per-transaction vendor supplying recurring medication needs across geographically distributed VA networks and correctional facilities. Recent representative work includes recurring $10.9 thousand purchase orders from VISN 2 for TARPEYO (budesonide) 4mg emergency supply; $38–$59 thousand monthly orders from Federal Medical Center Rochester for Crenessity medication; and $16 thousand quarterly Yorvipath supply orders from Federal Correctional Complex Butner. All identified work is categorized under PSC Drugs and Biologicals, with NAICS 325412 (Pharmaceutical Preparation Manufacturing) and 424210 (Drugs and Druggists' Sundries Merchant Wholesalers) accounting for substantially all awards.
All 53 awards are prime contracts with no subcontractor involvement recorded. Performance occurs at the vendor's Pittsburgh facility. Pantherx Specialty maintains registered specialty pharmacy status under Centene Corporation ownership and has operated in federal procurement since at least November 2019. The vendor specializes in sourcing and delivering difficult-to-obtain, specialized medications—including TARPEYO, Crenessity, Yorvipath, Ruzurgi, JOENJA, and Mavorixafor—to meet urgent clinical needs within federal healthcare systems, positioning itself as a targeted supplier for rare disease and emergency pharmaceutical requirements that standard commercial channels cannot fulfill rapidly.
Quick answers
Is Pantherx Specialty, LLC registered in SAM.gov?
Yes. Pantherx Specialty, LLC's SAM.gov registration is active through February 2, 2027.
How much has Pantherx Specialty, LLC received in federal contracts?
Federal contracts obligated $231,613 to Pantherx Specialty, LLC in fiscal year 2025 and $1,040,442 in fiscal years 2023 through 2027.
How does Pantherx Specialty, LLC rank among federal contractors?
Pantherx Specialty, LLC ranked #15 in NAICS 4242 in FY2025.
What is Pantherx Specialty, LLC's most recent federal award?
Pantherx Specialty, LLC's most recent federal contract award is Yorvipath medication DOS: QTR 1 PO (OCT 1- december 11, 2026) (15B10627P00000002), from Federal Correctional Complex Butner (BOP), on October 13, 2026.
On GovTribe
See Pantherx Specialty, LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors